Possible correction of defective polymorphonuclear cell functions in type-2 diabetes mellitus by met-enkephalin
- PMID: 3037972
- DOI: 10.1111/j.1749-6632.1987.tb35761.x
Possible correction of defective polymorphonuclear cell functions in type-2 diabetes mellitus by met-enkephalin
Abstract
In vitro pretreatment with Met-Enk of human PMNLs obtained from patients suffering from type-2 diabetes mellitus resulted in the normalization of the ROS generating system. It is assumed that Met-Enk has a modulating effect on the arachidonic acid metabolism, with a consecutive increase of the LTB4 release.
Similar articles
-
Concentration-dependent effect of met-enkephalin on human polymorphonuclear leukocytes.Ann N Y Acad Sci. 1987;496:151-7. doi: 10.1111/j.1749-6632.1987.tb35758.x. Ann N Y Acad Sci. 1987. PMID: 3474966
-
Interaction of met-enkephalin with human granulocytes.Ann N Y Acad Sci. 1987;496:146-50. doi: 10.1111/j.1749-6632.1987.tb35757.x. Ann N Y Acad Sci. 1987. PMID: 3037971
-
Met- and Leu-enkephalin modulate superoxide anion release from human polymorphonuclear cells.Ann N Y Acad Sci. 1992 Apr 15;650:146-53. doi: 10.1111/j.1749-6632.1992.tb49112.x. Ann N Y Acad Sci. 1992. PMID: 1318654 No abstract available.
-
[Methionine-enkephalin (Met-Enk) and leucine-enkephalin (Leu-Enk)].Nihon Rinsho. 2005 Aug;63 Suppl 8:211-2. Nihon Rinsho. 2005. PMID: 16149492 Review. Japanese. No abstract available.
-
Immunomodulating effects of methionine enkephalin.Zhongguo Yao Li Xue Bao. 1998 Jan;19(1):3-6. Zhongguo Yao Li Xue Bao. 1998. PMID: 10375747 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous